Adrenomedullin disrupts insulin signaling in blood vessels, leading to systemic insulin resistance in obesity-associated type 2 diabetes.

CIRM awards US$ 4 mn grant to Entos Pharma to advance development of ENTLEP001, a durable and redosable genetic medicine to treat CGL: San Diego Friday, February 7, 2025, 15:00 Hr ...

The hormone adrenomedullin disrupts insulin signaling in blood vessel cells, contributing to systemic insulin resistance in ...

The hormone adrenomedullin disrupts insulin signaling in blood vessel cells, contributing to systemic insulin resistance in obesity-associated type 2 ...

Congenital generalized lipodystrophy (CGL) is a rare autosomal recessive disorder characterized by a near-total absence of ...

For those who are not able to sleep properly, have a fluctuating weight, or suffer from certain diseases or conditions, you ...

Mitolyn, a natural option designed to support healthy mitochondrial function and, as a result, promote effective weight loss, is pleased to announce that it has released its innovative formula and ...

Body Mass Index (BMI) can be a screening tool, but obesity must be confirmed by measuring body fat, said health experts on Saturday, even as India revamped its obesity guidelines after 15 years.